Exploring the complexities of Pulmonary Hypertension

Pulmonary hypertension (PH) is a serious condition characterised by elevated blood pressure within the pulmonary arteries. The pulmonary arteries are responsible for carrying blood from the right-hand side of the heart to the lungs.

Milner Therapeutics Institute Director Professor Tony Kouzarides awarded a knighthood in King's Birthday Honours List

Professor Tony Kouzarides, Director of the Milner Therapeutics Institute, has been awarded a knighthood for services to healthcare innovation and delivery.

Gyros Protein Technologies introduces Gyrolab Generic Anti-AAV Kit to support gene therapy development

Ready-to-use kit enables detection of binding antibodies against AAV vectors without the need for serotype-specific assays

Animating the science of a firearm - WaveFX

WaveFX writes...our talented CG artists can bring any process to life, for example this STEM based client wanted to show the firing process of a firearm as part of a series of educational videos.

Price Bailey encourages Cambridge based healthcare businesses looking to sell, to act now

With the general election announced for July,  Price Bailey is urging healthcare businesses to sell up now to avoid potential post-election tax hikes. 

Enterprise Therapeutics appoints Dr Renu Gupta as Chief Medical Officer and Dr Janet Hammond as Non-Executive Director

Brighton, UK: Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of patients suffering from respiratory disease, announces the appointment of Dr Renu Gupta as CMO (Chief Medical

Sphere Fluidics awarded Gold accreditation by Investors in People

Internationally-recognized ‘We invest in people’ award is certified recognition of the Company’s care and commitment to its employees globally

Enterprise Therapeutics publishes preclinical profile of ETD001, a novel inhaled ENaC blocker

Low doses of ETD001 demonstrate exceptionally long duration of action in sheep model of airway mucus clearance Report in Journal of Cystic Fibrosis discloses best-in-class profile of ETD001 ETD001 scheduled to commence Phase 2 clinical study in p

Newcells Biotech strengthens executive and US team with key appointments

Dr Valeria Chichagova appointed as Director of Technology, Dr Colin Brown as Chief Scientific Officer, and Professor Lyle Armstrong as Scientific Advisor New US commercial appointments also announced to meet growing global demand for products and services

Cambridge-based Cofinitive Communications recognised amongst international PR and Communications industry elite

Cambridge-based PR & Comms agency, Cofinitive Communications has been listed in PR Week’s Top 150 PR agency rankings for a third consecutive year.

I do not live with diabetes – should I be monitoring my glucose with CGM?

Nowadays, CGMs are being promoted by various biotech companies and social media influencers as tools for understanding and improving health. Unfortunately, I can see a rise in poorly evidenced health messages. In addition, there are many misleading ads risking people’s health.

Nuclera awarded £1.14M Innovate UK funding for development of eProtein Discovery

£790k FASST grant, in collaboration with DeepMirror, and £350k Engineering Biology grant awarded for platform development.

MediMab Biotherapeutics opens bespoke laboratory facilities, created by Kadans Science Partner, at Abingdon Science Park, UK

New CL2 wet lab purpose-built facilities delivered by Kadans Science Partner will support MediMab Biotherapeutics to identify first-in-class immuno-oncology drugs that can actively target a range of advanced and solid tumours Kadans has also completed on Barton Hous

VALANX Biotech announces promising results in first in-vivo study of novel protein conjugate therapy

Study demonstrates pre-clinical efficacy of lead program VLX101 in treating autoimmune disease

Sphere Fluidics launches Cyto-CellectPLUS to accelerate cell line development workflows

Next-generation assay provides a rapid and cost-effective solution to quantify IgG production in single cells

Living with paediatric asthma

A number of different management techniques can help in controlling asthma in children. The aim of these management techniques is to enable the child to have a “normal life”, free of asthma symptoms.

Precision in every layer: celebrating over two decades of 3D printing innovation at IPFL

In the fast-evolving world of 3D printing, staying ahead of the curve means not only keeping pace with current trends but also pioneering new technologies. At IPFL (Industrial Plastic Fabrications Ltd), our unwavering commitment to innovation is evident in our rich history of over 55 years in bespoke plastic manufacturing and a remarkable 21-year journey in additive manufacturing.

Sable&Hawkes deliver campaign graphics and new product illustrations for global biotech

Sable&Hawkes have delivered product and marketing illustrations, icons and infographics for global biopharma and life sciences company Sartorius.

SolasCure selected for Innovate UK Global Incubator Programme in Houston

Programme delivered in partnership with the Texas Medical Centre Programme will support Aurase Wound Gel for future entry into US market, advancing SolasCure’s mission to transform chronic wound care for millions of patients worldwide

Cam

PhoreMost achieves second milestone in target discovery alliance with Boehringer Ingelheim

Milestone payment follows successful target identification and validation in separate project under same collaboration

DefiniGEN and Atelerix collaborate to ship in vitro cell models internationally without the need for freezing or cryopreservation

Cambridge and Newcastle UK: DefiniGEN Ltd., and Atelerix Ltd., announces they have successfully shipped in vitro liver models from the UK to a top tier pharma customer in the US.

Time from EMA approval to CT outcome for first indication vs. AMSR

This post launches a series of infographics focused on pricing and market access trends of rare disease treatments in France.

H.E.L Group extends sales and support with appointment of specialist distributors

Distributors will provide added application specific support for H.E.L’s biotechnology and chemical synthesis product portfolios in the USA, Spain and Portugal.

Impact of medicare price “negotiation” program on small and large molecule medicines

The Inflation Reduction Act (IRA) directs the U.S. federal government to set a “Maximum Fair Price” (MFP) for the medicines with the highest spending in Medicare.

Skylight Psychiatry joins Salus Wellness

Salus Wellness are happy to announce that Skylight Psychiatry has joined Salus Wellness this month. Skylight Psychiatry is a CQC regulated specialist multidisciplinary service for Adults. They support autistic people, people with Neurodevelopmental Disorders (ADHD, Learning Disabilities, Down Syndrome and others) and the Neurodiverse population who do not have a diagnosis and are in need of…